Table of Contents
Empagliflozin is a medication commonly prescribed to manage type 2 diabetes. As a member of the SGLT2 inhibitors, it helps lower blood sugar levels by promoting glucose excretion through the urine. Pharmacy technicians should be familiar with its potential side effects to ensure proper patient counseling and safety.
Common Side Effects
- Urinary tract infections (UTIs)
- Genital yeast infections
- Increased urination
- Dehydration
- Low blood pressure (hypotension)
These side effects are typically mild but require monitoring, especially in patients with risk factors such as kidney impairment or dehydration.
Serious Side Effects
- Diabetic ketoacidosis (DKA)
- Acute kidney injury
- Genital infections leading to complications
- Serious urinary tract infections
- Hypersensitivity reactions
Pharmacy technicians should be alert to symptoms such as severe abdominal pain, confusion, or rapid breathing, which may indicate DKA, a rare but serious side effect.
Patient Counseling Points
- Advise patients to maintain good hydration and monitor for signs of dehydration.
- Encourage proper genital hygiene to prevent infections.
- Inform patients about the importance of reporting symptoms like pain, fever, or unusual urination.
- Remind patients to attend regular blood tests to monitor kidney function.
- Discuss the importance of adhering to prescribed doses and not stopping medication without consulting a healthcare provider.
Understanding these side effects helps pharmacy technicians provide accurate information and ensure patient safety while using empagliflozin.